Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316420
Status:
COMPLETED
Last Update Posted:
2010-03-08
First Post:
2006-04-18
Brief Title:
Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
Sponsor:
Swedish Medical Center
Organization:
Swedish Medical Center
Organization Data
Organization:
Swedish Medical Center
Class:
OTHER
Study ID:
TI027 PGHK
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Swedish Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Philip Gold MD
Old Organization:
Swedish Medical Center Swedish Cancer Insitute
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |